
Vol. 40. Núm. 2. (marzo 2025)

Profundizando en la fatiga del síndrome post-COVID
Introducción Más de 100 millones de personas han sido infectadas en el mundo por el virus SARS-CoV-2, responsable de una enfermedad aguda denominada COVID-19. Múltiples estudios han mostrado cómo diversos síntomas en estos enfermos pueden […]

Beta-caryophyllene inhibits the permeability of the blood–brain barrier in MPTP-induced parkinsonism
Introduction Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Although the precise pathogenesis of PD remains unclear, several studies demonstrate that oxidative stress, inflammation, low levels of antioxidants, and the presence of […]

Estudio de la situación actual del Teleictus en España
Introducción En los últimos años se ha establecido el uso del Teleictus como una herramienta fundamental para extender la atención a los pacientes con ictus agudo hasta hospitales que no disponen de neurólogos de guardia. […]

Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations
Background Different types of therapies were proven effective for the medical management of motor and non-motor symptoms in Parkinson’s disease (PD). We aimed to gain consensus on the dopamine agonist (DA) therapy use in different […]

Mortality rates for Parkinson’s disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020
Background Mortality in Parkinson’s disease is increasing worldwide, but Spanish data need further study. Objective To analyse the mortality trends of Parkinson’s disease in Spain between 1981 and 2020. Methods This observational retrospective study assessed […]

Exonic variants of the P2RX7 gene in familial multiple sclerosis
Introduction Several studies have analysed the presence of P2RX7 variants in patients with MS, reporting diverging results. Methods Our study analyses P2RX7 variants detected through whole-exome sequencing (WES). Results We analysed P2RX7, P2RX4, and CAMKK2 […]
Selección de pacientes para cierre percutáneo en el ictus isquémico no lacunar criptogénico asociado a foramen oval permeable. Datos del registro cooperativo NORDICTUS
Introducción El tratamiento mediante cierre percutáneo está extendiendo su uso en el ictus asociado a foramen oval permeable (FOP). El objetivo del estudio es analizar la práctica clínica del cierre percutáneo de FOP y conocer […]